Food and Drug Administration
Dermatologic and Ophthalmic Drugs Advisory Committee Meeting
Open Public Hearing
May 23, 2002
Testimony to the FDA Dermatologic and Ophthalmic Drugs Advisory Committee, Gail Zimmerman, Nat'l Psoriasis Foundation htm ppt